MOUNJARO Use in Combination with Basal Insulin with or without Metformin in Adult Patients with Type 2 Diabetes Mellitus SURPASS-5 (NCT04039503) was a 40-week double-blind trial that randomized 475 adult patients with type 2 diabetes mellitus with inadequate glycemic control on insulin glargine 100 units/mL, with or without metformin, to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or placebo
Lets take a closer look at how each of these medications helps with weight loss
Improved blood sugar regulation: GLP-1 injections stimulate the pancreas to release insulin after meals, which helps lower blood sugar levels
Cranberry capsules are preferable to juice when on tirzepatide, as they avoid the sugar content that can interfere with blood sugar management and dietary goals
For patients who do not respond strongly to traditional appetite suppressants alone, topiramate can provide a different mechanism of support that improves eating behavior and consistency
Several factors influence your results, including: Starting Weight: People with more weight to lose often see faster early changes